首页> 外文期刊>Journal of cellular biochemistry. >The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively.
【24h】

The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively.

机译:PKCalpha和PKCbetaI易位的CD14 +单核细胞分化为巨噬细胞和树突状细胞的必要性。

获取原文
获取原文并翻译 | 示例
           

摘要

Human peripheral CD14(+)monocytes have been known to differentiate into monocyte-derived macrophages (MDMs) or dendritic cells (MoDCs) upon suitable stimulation. However, the key intracellular molecule(s) associated with their differentiation towards specific cell types was(were) not fully understood. This study was designated to determine the association of PKC isoenzymes with the differentiation of CD14(+)monocytes into MDMs or MoDCs. Purified human peripheral CD14(+)monocytes were cultured with GM-CSF, or GM-CSF plus IL-4 for 7 days to induce cell differentiation. The phenotypic changes were analyzed by Flow-Cytometry using various specific antibodies to cell type-specific surface markers. The immunological functions of these differentiated cells were determined by measuring the amounts of TNF-alpha secretion for MDMs, and the capacities of antigen-capturing and bacterial phagocytosis for MoDCs. The translocations of PKC isoenzymes in these cells from cytosol to plasma membrane were examined by Western Blot analysis and Confocal Microscopic observation. The treatment of CD14(+)monocytes with either GM-CSF or PMA elicited PKCalpha translocation and consequently induced their differentiation into MDMs. The inclusion of PKCalpha/beta(I) specific inhibitor, Go6976, greatly inhibited the GM-CSF-induced PKCalpha translocation and dose-dependently reduced the GM-CSF- induced MDM differentiation. On the other hand, the simultaneous pretreatment of CD14(+)monocytes with Go6976 and PKCbeta-specific inhibitor predominantly suppressed the GM-CSF/IL-4-induced generation of MoDCs. Further study demonstrated that GM-CSF/IL-4 selectively induced the translocation of PKCbeta(I), not PKCalpha or PKCbeta(II), in CD14(+)monocytes. In conclusion, the cell fate commitment of CD14(+)monocytes towards MDMs or MoDCs appears to be steered by the selective activation of PKCalpha or PKCbeta(I), respectively.
机译:已知人类外周CD14(+)单核细胞在适当刺激下可分化为单核细胞衍生的巨噬细胞(MDM)或树突状细胞(MoDC)。然而,尚未完全了解与它们向特定细胞类型分化有关的关键细胞内分子。这项研究的目的是确定PKC同工酶与CD14(+)单核细胞分化成MDM或MoDC的关联。纯化的人外周血CD14(+)单核细胞与GM-CSF或GM-CSF加IL-4培养7天,以诱导细胞分化。使用各种针对细胞类型特异性表面标记的特异性抗体,通过流式细胞术分析表型变化。这些分化细胞的免疫功能通过测量MD​​M的TNF-α分泌量以及MoDC的抗原捕获和细菌吞噬能力来确定。通过蛋白质印迹分析和共聚焦显微镜观察检查了PKC同工酶在这些细胞中从胞浆到质膜的转运。 GM-CSF或PMA对CD14(+)单核细胞的治疗引起PKCalpha易位,并因此诱导其分化为MDM。 PKCalpha / beta(I)特异性抑制剂Go6976的加入极大地抑制了GM-CSF诱导的PKCalpha移位,并剂量依赖性地降低了GM-CSF诱导的MDM分化。另一方面,同时用Go6976和PKCbeta特异性抑制剂预处理CD14(+)单核细胞主要抑制了GM-CSF / IL-4诱导的MoDC生成。进一步的研究表明,GM-CSF / IL-4在CD14(+)单核细胞中选择性诱导PKCbeta(I)而不是PKCalpha或PKCbeta(II)易位。总之,CD14(+)单核细胞对MDM或MoDC的细胞命运承诺似乎分别通过选择性激活PKCalpha或PKCbeta(I)来控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号